Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 2Not yet recruiting 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4UNKNOWN 1OTHER_GOV 1NETWORK 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Breast 7

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

palbociclib 1S 1 (combination) 1Re-Irradiation 1Docetaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Breast Cancer Recurrent × Clear all
NCT07612254 2026-05-28

REPEAT

Dartmouth-Hitchcock Medical Center

Phase 1/2 Not yet recruiting
30 enrolled
Breast

Breast Cancer Recurrent

NCT03820830 2026-04-09

POLAR

ETOP IBCSG Partners Foundation

Phase 3 Active not recruiting
405 enrolled
Breast

Breast Cancer Recurrent

NCT05464082 2026-02-20

TOWARDS-II

University of Utah

Phase 2 Recruiting
80 enrolled
Breast

Breast Cancer Recurrent

NCT06458413 2024-06-13

Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Henan Cancer Hospital

Phase 2 Recruiting
40 enrolled
Breast

Breast Cancer Recurrent

NCT05406661 2023-10-19

R_ReLoCC

Universidade do Porto

Not yet recruiting
3,000 enrolled
Breast

Breast Cancer Recurrent

NCT02947061 2016-10-31

S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer

ChineseAMS

Phase 2 Unknown
300 enrolled
Breast

Breast Cancer Recurrent

NCT01552655 2015-04-21

BREAC-AUT

Odense University Hospital

Phase NA Completed
101 enrolled
Breast

Breast Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡